Comparison of tadalafil pharmacokinetics after administration of a new orodispersible film versus a film-coated tablet
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Sang-In | - |
dc.contributor.author | Heo, Su-Hak | - |
dc.contributor.author | Kim, Gihwan | - |
dc.contributor.author | Chang, Seokhoon | - |
dc.contributor.author | Song, Keon-Hyoung | - |
dc.contributor.author | Kim, Min-Gul | - |
dc.contributor.author | Jin, Eun-Heui | - |
dc.contributor.author | Kim, JaeWoo | - |
dc.contributor.author | Lee, SeungHwan | - |
dc.contributor.author | Hong, Jang Hee | - |
dc.date.accessioned | 2021-08-11T13:43:57Z | - |
dc.date.available | 2021-08-11T13:43:57Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1177-8881 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/6831 | - |
dc.description.abstract | Background: An orodispersible film (ODF) of tadalafil may provide increased convenience for erectile dysfunction (ED) patients as compared to conventional tablet formulations. In this study, we aimed to compare the pharmacokinetic, safety, and tolerability profiles of a newly developed ODF formulation of tadalafil to those of a film-coated tablet (FCT) of tadalafil. Materials and methods: This study was conducted in healthy male subjects using an openlabel, randomized sequence, two-period, two-formulation, single-dose, crossover design. The subjects were randomly assigned to one of two sequences of the two formulations: both the test drug (ODF) and the reference drug (FCT) contained 20 mg of tadalafil. Blood samples were collected up to 72 h after administration. Plasma concentrations of tadalafil were analyzed using liquid chromatography-tandem mass spectrometry. Geometric mean ratios (GMRs) of the ODF to FCT formulations and their 90% CIs for the pharmacokinetic parameters were estimated. Safety and tolerability were assessed throughout the study. Results: Forty healthy male subjects were enrolled, and 36 of these completed the study. The GMRs (90% CIs) of the maximum plasma concentration and the area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration for tadalafil were 0.927 (0.882-0.974) and 0.972 (0.918-1.029), respectively. Both ODF and FCT formulations were well tolerated, and no clinically significant changes from the baseline were observed after dosing. Conclusion: The pharmacokinetics of the tadalafil ODF formulation did not differ significantly from those of the FCT formulation. Furthermore, the safety and tolerability profiles of the ODF formulation were comparable to those of the FCT formulation. Therefore, this tadalafil ODF formulation offers a convenient treatment option for patients with erectile dysfunction. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Dove Medical Press Ltd | - |
dc.title | Comparison of tadalafil pharmacokinetics after administration of a new orodispersible film versus a film-coated tablet | - |
dc.type | Article | - |
dc.publisher.location | 뉴질랜드 | - |
dc.identifier.doi | 10.2147/DDDT.S155040 | - |
dc.identifier.scopusid | 2-s2.0-85046296648 | - |
dc.identifier.wosid | 000431276500001 | - |
dc.identifier.bibliographicCitation | Drug Design, Development and Therapy, v.12, pp 935 - 942 | - |
dc.citation.title | Drug Design, Development and Therapy | - |
dc.citation.volume | 12 | - |
dc.citation.startPage | 935 | - |
dc.citation.endPage | 942 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ERECTILE DYSFUNCTION | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | erectile dysfunction | - |
dc.subject.keywordAuthor | orodispersible film | - |
dc.subject.keywordAuthor | tadalafil | - |
dc.subject.keywordAuthor | pharmacokinetics | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.